Virtual Medicinal Product (VMP) - Physostigmine salicylate 2mg/2ml solution for injection ampoules
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Physostigmine salicylate 2mg/2ml solution for injection ampoules | Start Date 17-02-2012 | End Date |
| Abbreviated Name | Abbreviated Name Physostigmine salicylate 2mg/2ml inj ampoules | Start Date 17-02-2012 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2.0
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular
- Name Basis
- BANM - British Approved Name (Modified)
Codes
- ATC Code
- V03AB19
| Code | Start Date | End Date |
|---|---|---|
| 20066611000001103 | 17-02-2012 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Physostigmine salicylate | Based on Ingredient Substance | 1 mg | 1 ml |
Name
Physostigmine salicylate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMPhysostigmine
-
VMP(Current) Physostigmine salicylate 2mg/2ml sol...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ampoule | ||
| 10 ampoule |